Interferon gamma
|
Ifng |
P01581 |
Impaired glucose tolerance
|
Ferrannini, E. et al. (Diabetologia, 2009), Sparso, T. et al. (Diabetes, 2009), Liu, J. et al. (Nat Med, 2009), Wu, H. et al. (Arterioscler Thromb Vasc Biol, 2010), Kong, L. et al. (Acta Diabetol, 2011)
|
Apolipoprotein E
|
Apoe |
P08226 |
Impaired glucose tolerance
|
Niemi, M. et al. (Gut, 1999), Zhou, Z. et al. (Neurology, 2005), Arbones-Mainar, J. M. et al. (FASEB J, 2010), Winocour, P. H. et al. (Atherosclerosis, 1989)
|
Apolipoprotein E
|
Apoe |
P02650 |
Impaired glucose tolerance
|
Niemi, M. et al. (Gut, 1999), Zhou, Z. et al. (Neurology, 2005), Arbones-Mainar, J. M. et al. (FASEB J, 2010), Winocour, P. H. et al. (Atherosclerosis, 1989)
|
Serpin family E member 1
|
SERPINE1 |
G9KN61 |
Impaired glucose tolerance
|
Tamura, Y. et al. (Diabetes, 2015), Niskanen, L. et al. (Metabolism, 1997)
|
Plasminogen activator inhibitor 1
|
Serpine1 |
P22777 |
Impaired glucose tolerance
|
Tamura, Y. et al. (Diabetes, 2015), Niskanen, L. et al. (Metabolism, 1997)
|
Plasminogen activator inhibitor 1
|
Serpine1 |
P20961 |
Impaired glucose tolerance
|
Tamura, Y. et al. (Diabetes, 2015), Niskanen, L. et al. (Metabolism, 1997)
|
Intercellular adhesion molecule 1
|
Icam1 |
P13597 |
Impaired glucose tolerance
|
Bluher, M. et al. (Diabetologia, 2002), Ren, B. et al. (Eur J Pharmacol, 2016)
|
Intercellular adhesion molecule 1
|
Icam1 |
Q00238 |
Impaired glucose tolerance
|
Bluher, M. et al. (Diabetologia, 2002), Ren, B. et al. (Eur J Pharmacol, 2016)
|
Monocyte differentiation antigen CD14
|
Cd14 |
P10810 |
Impaired glucose tolerance
|
Fernandez-Real, J. M. et al. (Diabetes, 2011)
|
Ubiquitin carboxyl-terminal hydrolase isozyme L1
|
Uchl1 |
Q9R0P9 |
Impaired glucose tolerance
|
Chu, K. Y. et al. (Diabetologia, 2012)
|
Ubiquitin carboxyl-terminal hydrolase isozyme L1
|
Uchl1 |
Q00981 |
Impaired glucose tolerance
|
Chu, K. Y. et al. (Diabetologia, 2012)
|
Growth hormone receptor
|
Ghr |
P16882 |
Impaired glucose tolerance
|
Mavalli, M. D. et al. (J Clin Invest, 2010)
|
Insulin-degrading enzyme
|
Ide |
Q9JHR7 |
Impaired glucose tolerance
|
Kwak, S. H. et al. (Diabetes Res Clin Pract, 2008), Tang, W. J. (Trends Endocrinol Metab, 2016)
|
Insulin-degrading enzyme
|
Ide |
P35559 |
Impaired glucose tolerance
|
Kwak, S. H. et al. (Diabetes Res Clin Pract, 2008), Tang, W. J. (Trends Endocrinol Metab, 2016)
|
Aspartate aminotransferase, cytoplasmic
|
Got1 |
P05201 |
Impaired glucose tolerance
|
Miyake, Y. et al. (J Hepatol, 2003)
|
Aspartate aminotransferase, cytoplasmic
|
Got1 |
Q64570 |
Impaired glucose tolerance
|
Miyake, Y. et al. (J Hepatol, 2003)
|
Alanine aminotransferase 1
|
Gpt |
Q8QZR5 |
Impaired glucose tolerance
|
Miyake, Y. et al. (J Hepatol, 2003)
|
Low molecular weight phosphotyrosine protein phosphatase
|
Acp1 |
Q9D358 |
Impaired glucose tolerance
|
Mok, A. et al. (J Clin Endocrinol Metab, 2002)
|
Acp1 protein
|
Acp1 |
B0BNC1 |
Impaired glucose tolerance
|
Mok, A. et al. (J Clin Endocrinol Metab, 2002)
|
Probetacellulin
|
Btc |
Q05928 |
Impaired glucose tolerance
|
Song, M. Y. et al. (Exp Mol Med, 2014)
|
14-3-3 protein zeta/delta
|
Ywhaz |
P63101 |
Impaired glucose tolerance
|
Hui, D. Y. et al. (Br J Pharmacol, 2009)
|
14-3-3 protein zeta/delta
|
Ywhaz |
P63102 |
Impaired glucose tolerance
|
Hui, D. Y. et al. (Br J Pharmacol, 2009)
|
14-3-3 protein zeta/delta
|
Ywhaz |
P35215 |
Impaired glucose tolerance
|
Hui, D. Y. et al. (Br J Pharmacol, 2009)
|
Hemoglobin subunit alpha
|
Hba |
P01942 |
Impaired glucose tolerance
|
Solomon, M. P. et al. (J Pediatr, 2003)
|
Peroxiredoxin-4
|
Prdx4 |
O08807 |
Impaired glucose tolerance
|
Ding, Y. et al. (Antioxid Redox Signal, 2010)
|